Understanding the interplay of FGFR signaling with pathways like JAK/STAT may provide new insights into the mechanisms driving tumor progression and resistance, particularly in cancers characterized by high plasticity and phenotypic heterogeneity. Here, SOAT1 is linked to neoplasm.